日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

基因组规模的 CRISPR 筛选发现 PTGES3 是晚期前列腺癌中雄激素受体功能的直接调节因子

Haolong Li,James E Melnyk,Becky Xu Hua Fu,Raunak Shrestha,Meng Zhang,Martin Sjöström,Siyu Feng,Jasmine A Anderson,Wanting Han,Lisa N Chesner,Hyun Jin Shin,Tatyanah Farsh,Humberto J Suarez,Seema Nath,Jonathan Chou,Rajdeep Das,Emily A Egusa,Marsha Calvert,Audrey Kishishita,Abhilash Barpanda,Jun Zhu,Ashutosh Maheshwari,William S Chen,Mohammed Alshalalfa,Aidan Winters,Junjie T Hua,Tianyi Liu,Elai Davicioni,Arun P Wiita,Bradley A Stohr,Javed Siddiqui,Bo Huang,Eric J Small,Kevan M Shokat,Peter S Nelson,David A Quigley,Elizabeth V Wasmuth,Luke A Gilbert,Felix Y Feng

Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression

膀胱癌变异株具有一些共同的侵袭性特征,包括CA125阳性细胞状态和可靶向的TM4SF1表达。

Heiko Yang #,Hanbing Song #,Elizabeth Yip,Timothy Gilpatrick,Kevin Chang,Paul Allegakoen,Kevin L Lu,Keliana Hui,Julia H Pham,Corynn Kasap,Vipul Kumar,Janae Gayle,Bradley A Stohr,Chien-Kuang Cornelia Ding,Arun P Wiita,Maxwell V Meng,Jonathan Chou,Sima P Porten,Franklin W Huang

PET Imaging Using 89Zr-Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention in Prostate Cancer

利用 89Zr 标记的 StarPEG 纳米载体进行 PET 成像揭示了前列腺癌中异质性增强的渗透性和滞留性

Niranjan Meher,Anil P Bidkar,Anju Wadhwa,Kondapa Naidu Bobba,Suchi Dhrona,Chandrashekhar Dasari,Changhua Mu,Cyril O Y Fong,Juan A Cámara,Umama Ali,Megha Basak,David Bulkley,Veronica Steri,Shaun D Fontaine,Jun Zhu,Adam Oskowitz,Rahul R Aggarwal,Renuka Sriram,Jonathan Chou,David M Wilson,Youngho Seo,Daniel V Santi,Gary W Ashley,Henry F VanBrocklin,Robert R Flavell

Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5

使用 134Ce/225Ac-Macropa-PEG4-YS5 开发针对前列腺癌的 CD46 靶向 α 治疗诊断剂

Kondapa Naidu Bobba, Anil P Bidkar, Anju Wadhwa, Niranjan Meher, Suchi Drona, Alexandre M Sorlin, Scott Bidlingmaier, Li Zhang, David M Wilson, Emily Chan, Nancy Y Greenland, Rahul Aggarwal, Henry F VanBrocklin, Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Robert R Flavell

CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13

CDK12 缺失驱动前列腺癌进展、转录-复制冲突以及与旁系同源基因 CDK13 的合成致死性

Jean Ching-Yi Tien ,Jie Luo ,Yu Chang ,Yuping Zhang ,Yunhui Cheng ,Xiaoju Wang ,Jianzhang Yang ,Rahul Mannan ,Somnath Mahapatra ,Palak Shah ,Xiao-Ming Wang ,Abigail J Todd ,Sanjana Eyunni ,Caleb Cheng ,Ryan J Rebernick ,Lanbo Xiao ,Yi Bao ,James Neiswender ,Rachel Brough ,Stephen J Pettitt ,Xuhong Cao ,Stephanie J Miner ,Licheng Zhou ,Yi-Mi Wu ,Estefania Labanca ,Yuzhuo Wang ,Abhijit Parolia ,Marcin Cieslik ,Dan R Robinson ,Zhen Wang ,Felix Y Feng ,Jonathan Chou ,Christopher J Lord ,Ke Ding ,Arul M Chinnaiyan

CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality

CDK12 缺失会促进前列腺癌的发展,同时暴露出基于旁系同源物的合成致死性的弱点

Jean Ching-Yi Tien, Yu Chang, Yuping Zhang, Jonathan Chou, Yunhui Cheng, Xiaoju Wang, Jianzhang Yang, Rahul Mannan, Palak Shah, Xiao-Ming Wang, Abigail J Todd, Sanjana Eyunni, Caleb Cheng, Ryan J Rebernick, Lanbo Xiao, Yi Bao, James Neiswender, Rachel Brough, Stephen J Pettitt, Xuhong Cao, Stephanie

Large tandem duplications in cancer result from transcription and DNA replication collisions

癌症中的大量串联重复是由转录和 DNA 复制碰撞引起的

Yang Yang, Michelle L Badura, Patrick C O'Leary, Henry M Delavan, Troy M Robinson, Emily A Egusa, Xiaoming Zhong, Jason T Swinderman, Haolong Li, Meng Zhang, Minkyu Kim, Alan Ashworth, Felix Y Feng, Jonathan Chou, Lixing Yang

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

小细胞神经内分泌前列腺癌中DLL3的免疫治疗靶向和PET成像

Jonathan Chou #,Emily A Egusa #,Sinan Wang #,Michelle L Badura,Fei Lee,Anil P Bidkar,Jun Zhu,Tanushree Shenoy,Kai Trepka,Troy M Robinson,Veronica Steri,Jiaoti Huang,Yuzhuo Wang,Eric J Small,Emily Chan,Bradley A Stohr,Alan Ashworth,Brant Delafontaine,Sylvie Rottey,Keegan S Cooke,Nooshin Hashemi Sadraei,Brian Yu,Mark Salvati,Julie M Bailis,Felix Y Feng,Robert R Flavell,Rahul Aggarwal

Theranostic Targeting of CUB Domain-Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer

针对膀胱癌多种亚型中含CUB结构域蛋白1 (CDCP1) 的诊疗一体化靶向治疗

Shalini Chopra ,Kai Trepka ,Sasank Sakhamuri ,Alberto Carretero-González ,Jun Zhu ,Emily Egusa ,Jie Zhou ,Kevin Leung ,Ning Zhao ,Nima Hooshdaran ,Felix Y Feng ,James A Wells ,Jonathan Chou ,Michael J Evans

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

CUB 结构域蛋白 1 (CDCP1) 是去势抵抗性前列腺癌(包括 PSMA 基因缺失疾病)的放射配体治疗靶点

Ning Zhao, Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran, Hyunjung Kim, Jie Zhou, Shion A Lim, Kevin K Leung, Emily A Egusa, Jun Zhu, Li Zhang, Adam Foye, Renuka Sriram, Emily Chan, Youngho Seo, Felix Y Feng, Eric J Small, Jonathan Chou, James A Wells, Rahul Aggarwal,